Medicomp, diagnostic cardiology leaders since 1981, is proud to announce that MedTech Outlook magazine has recognized Medicomp as a Top 10 Cardiovascular Device Company for 2018. MedTech Outlook, a leading medical technologies journal for health care professionals, recognizes 10 companies each year that are “at the forefront of tackling customer challenges.” This list then helps physicians and organizations select the best providers that “offer the most promising solutions.”
Medicomp, which develops, manufactures, and distributes cardiac monitoring devices, has been an innovator in ambulatory cardiac monitoring since 1981. Using diagnostic technologies that are considered highly advanced within the industry, Medicomps monitors have been used by both the US military and on the International Space Station. Their latest cardiac monitoring technology, TelePatchTM, is a versatile 3-in-1 monitor that combines the power of a short- and long-term Holter, wireless event monitor, and a mobile cardiac telemetry unit into one compact, wearable patch.
Medicomp is known for exceeding both physician and patient needs, providing patient-friendly, no-hassle billing practices that focus on a seamless integration into practices. “Physicians will increasingly rely on Medicomp in the consumer-connected health care world as it rapidly advances, particularly in the realm of the[Inter]net of Things and medical wearables,” says Tony Balda, President and CEO of Medicomp. With their dedication to cutting-edge technological advancement and research, Medicomp is surely paving the path for the future of diagnostics.
Read Medtech Outlook’s interview with Tony Balda here.
Founded in 1981, Medicomp is recognized as a technology leader in the telemedicine industry, pioneering cutting-edge products and services, and developing new applications that result in better clinical outcomes across multiple specialties. Medicomp’s four clinical monitoring centers across the United States are staffed 24 hours a day, 365 days a year, providing remote monitoring to patients throughout the world. For more information, click here, or call (800) 23-HEART.